MindTech Therapeutics – The Development of Psychedelic Medicines to Treat Mental Illnesses, Drug Addictions & Anxiety Disorders.
Jerry Martin - Vancouver, British Columbia, CanadaPresident
Canadian Drug Reform Advocate Jerry Martin has dedicated much of his adult life to fighting for Canadians to have fair access to medical cannabis. Originally from Vancouver, he is well known across Western Canada for his drug reformation activism and advocacy. He has become a prominent figure in the cannabis and psychedelic communities and champions the decriminalization and legalization of psychedelics along with the constitutional right for medical cannabis users to access local dispensaries.
Dr Richard Knowles Ph.D. - Silicon Valley, California, USAVice President/Chief Science Director
Dr. Richard Knowles is a licensed psychologist working at a psychiatry and psychotherapy clinic in the San Francisco Bay Area. He is the founder and executive director of Delos Psyche Research Group. He has served as faculty at Sofia University, teaching classes on psychology and consciousness studies. As a researcher, his topics of inquiry include consciousness studies, altered states of consciousness, psychedelic studies, and exceptional human experience. He also works for the Multidisciplinary Association of Psychedelic Studies (MAPS) as a lead adherence rater for their MDMA-assisted psychotherapy research treating PTSD, and looks forward to conducting a wide variety of psychedelic research in the future.
Chief Medical Officer/Chief Executive Officer
Paul Lewin - Toronto, Ontario, CanadaSenior Law Advisor - Lewin & Sagara LLP
Paul Lewin has been a criminal defence lawyer in Toronto and across Canada for over 20 years. His focus concerns litigation and consultation on matters related to the cannabis plant and psychedelics. He advocates for cannabis rights with the National Organization for the Reform of Marijuana Laws in Canada.
Jack Lloyd - Toronto, Ontario, CanadaPsychedelics Law Expert
Jack Lloyd wears many hats. He is a trusted Toronto cannabis lawyer who has made a career out of correcting the historical wrongs of cannabis illegality. He is also an editor at the publishing company Green Candy Press, which is the largest publisher of books about the cannabis plant in the world. He is the editor of the Psilocybin Mushroom Bible. Jack thinks that some really great legal work can be done advocating for the use of certain hallucinogens for therapeutic purposes and he is happy to do it.
Michael Starogiannis, P.Eng., MBA - Toronto, Ontario, CanadaDirector of Corporate Development
Michael Starogiannis brings over 24 years of experience in various capacities of analysis, design, governance, and project management to Microdosing Canada. He refines business plans and advances entrepreneurial projects from concept to reality. When not assisting small companies and start-ups with business strategy, corporate development, and financial modelling, Michael serves on the Board of Directors of Sailfish Royalty Corp and also works as a part time Instructor at the Faculty of Applied Science and Engineering at the University of Toronto teaching Mine Economics. Prior to his time in business consultancy, mining finance and work as an investment analyst, Michael practiced as a Professional Engineer in the mining and heavy civil infrastructure sectors.
Henria Stephens has worked in the Agriculture, Healthcare and International Development Sector for nearly 20 years. She is a champion of justice and fairness and returned to law school to hone her advocacy skills. As an articling student working jointly with Lewin&Sagara and Cannabis Law, she is happy to contribute to this dedicated and innovative team.
Daniel Perlin - Toronto, Ontario, CanadaCorporate Law Expert
Dr Vince Polito Ph.D. - New South Wales, AustraliaDepartment of Cognitive Science Macquarie University
Dr. Vince Polito is a Postdoctoral Research Fellow in the Department of Cognitive Science at Macquarie University. His research investigates consciousness, beliefs and self representation. His PhD research won the Ernest Hilgard Award from the American Psychological Association. In February 2019 he published the first longitudinal study on the effects of microdosing psychedelics.